M Jaffry, F Mostafa, K Mandava, S Rosario, Y Jagarlamudi, K Jaffry, J Kornitzer, K Jedidi, H Khan, N Souayah
OBJECTIVE: To investigate the association between Guillain-Barré syndrome (GBS) and COVID-19 vaccination. BACKGROUND: On July 13, 2021, the US Food and Drug Administration (FDA) released a new warning that Johnson & Johnson COVID-19 vaccine could increase the risk of developing GBS. METHODS: The reporting rate of adult GBS after COVID-19 vaccination, ascertained with Brighton criteria, was compared with the reporting rate after other vaccinations during the same time period, and also compared with the reporting rate during control periods...
September 22, 2022: Vaccine